Skip to main content

Table 3 Antibiotic susceptibilities of different blood culture isolates

From: Post-ERCP infection and its epidemiological and clinical characteristics in a large Chinese tertiary hospital: a 4-year surveillance study

Antibiotics Enterococcus faecium Escherichia coli Klebsiella pneumonia Pseudomonas aeruginosa Acinetobacter baumannii Enterobacter cloacae
Aamikacin 100%(11/11) 100%(5/5) 40%(2/5) 100%(4/4)
Ampicillin 8%(1/12) 14%(1/7) 0%(0/4) 0%(0/5) 0%(0/4) 0%(0/2)
Aztreonam 38%(3/8) 100%(4/4) 50%(2/4) 0%(0/3) 50%(1/2)
Nitrofurantoin 33%(4/12) 63%(5/8) 50%(2/4) 0%(0/3) 0%(0/3) 50%(1/2)
Ciprofloxacin 0%(0/12) 27%(3/11) 80%(4/5) 60%(3/5) 0%(0/4) 100%(4/4)
Gentamicin 38%(3/8) 75%(6/8) 100%(4/4) 33%(1/3) 33%(1/3) 100%(2/2)
Cefazolin 0%(0/6) 0%(0/4) 0%(0/3) 0%(0/3) 0%(0/2)
Ceftazidime 45%(5/11) 80%(4/5) 60%(3/5) 0%(0/4) 25%(1/4)
Ceftriaxone 38%(3/8) 75%(3/4) 0%(0/3) 0%(0/3) 50%(1/2)
Cefepime 64%(7/11) 80%(4/5) 40%(2/5) 0%(0/4) 75%(3/4)
Vancomycin 100%(12/12)
Linezolid 100%(12/12)
Imipenem 100%(11/11) 100%(5/5) 20%(1/5) 0%(0/4) 100%(4/4)
Levofloxacin 0%(0/8) 29%(2/7) 100%(4/4) 60%(3/5) 0%(0/3) 100%(2/2)